Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spiral CT Will Be Compared With Chest X-Ray In NCI Lung Screening Trial

This article was originally published in The Gray Sheet

Executive Summary

Enrollment in a National Cancer Institute-sponsored lung screening trial comparing spiral CT to chest x-ray will be complete in one to two years, NCI says

You may also be interested in...



National Lung Screening Trial

National Cancer Institute's NLST trial completes enrollment goal of 50,000 participants, NCI announces. The lung screening study comparing spiral CT with chest x-ray began in September 2002 (1"The Gray Sheet" Sept. 23, 2002, p. 6)...

National Lung Screening Trial

National Cancer Institute's NLST trial completes enrollment goal of 50,000 participants, NCI announces. The lung screening study comparing spiral CT with chest x-ray began in September 2002 (1"The Gray Sheet" Sept. 23, 2002, p. 6)...

CAD Impact On Clinical Decisions Warrants Guidance Document – Philips Rep

The relationship between the performance of computer-aided detection (CAD) technologies and actual clinical outcomes merits clarification from FDA and CMS, according to Philips Nuclear Medicine Chief Medical Officer David Rollo

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel